1. Home
  2. PCVX vs RUN Comparison

PCVX vs RUN Comparison

Compare PCVX & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • RUN
  • Stock Information
  • Founded
  • PCVX 2013
  • RUN 2007
  • Country
  • PCVX United States
  • RUN United States
  • Employees
  • PCVX N/A
  • RUN N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • RUN Industrial Machinery/Components
  • Sector
  • PCVX Health Care
  • RUN Miscellaneous
  • Exchange
  • PCVX Nasdaq
  • RUN Nasdaq
  • Market Cap
  • PCVX 4.0B
  • RUN 3.7B
  • IPO Year
  • PCVX 2020
  • RUN 2015
  • Fundamental
  • Price
  • PCVX $43.49
  • RUN $20.12
  • Analyst Decision
  • PCVX Strong Buy
  • RUN Buy
  • Analyst Count
  • PCVX 8
  • RUN 20
  • Target Price
  • PCVX $114.17
  • RUN $18.47
  • AVG Volume (30 Days)
  • PCVX 2.2M
  • RUN 10.5M
  • Earning Date
  • PCVX 11-04-2025
  • RUN 11-06-2025
  • Dividend Yield
  • PCVX N/A
  • RUN N/A
  • EPS Growth
  • PCVX N/A
  • RUN N/A
  • EPS
  • PCVX N/A
  • RUN N/A
  • Revenue
  • PCVX N/A
  • RUN $2,129,272,000.00
  • Revenue This Year
  • PCVX N/A
  • RUN $11.64
  • Revenue Next Year
  • PCVX N/A
  • RUN $8.79
  • P/E Ratio
  • PCVX N/A
  • RUN N/A
  • Revenue Growth
  • PCVX N/A
  • RUN 3.27
  • 52 Week Low
  • PCVX $27.66
  • RUN $5.38
  • 52 Week High
  • PCVX $118.62
  • RUN $22.44
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 68.94
  • RUN 58.87
  • Support Level
  • PCVX $42.75
  • RUN $18.10
  • Resistance Level
  • PCVX $45.12
  • RUN $22.44
  • Average True Range (ATR)
  • PCVX 2.10
  • RUN 1.33
  • MACD
  • PCVX 0.41
  • RUN 0.08
  • Stochastic Oscillator
  • PCVX 84.68
  • RUN 58.52

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

Share on Social Networks: